Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$306.88 - $380.0 $62,910 - $77,900
205 Added 12.99%
1,783 $674,000
Q3 2023

Nov 14, 2023

BUY
$315.92 - $397.36 $106,465 - $133,910
337 Added 27.16%
1,578 $501,000
Q2 2023

Aug 11, 2023

BUY
$346.15 - $392.09 $186,921 - $211,728
540 Added 77.03%
1,241 $475,000
Q1 2023

May 12, 2023

BUY
$323.56 - $373.36 $54,681 - $63,097
169 Added 31.77%
701 $261,000
Q4 2022

Feb 13, 2023

BUY
$248.67 - $334.17 $18,650 - $25,062
75 Added 16.41%
532 $175,000
Q3 2022

Nov 14, 2022

BUY
$263.81 - $337.27 $57,510 - $73,524
218 Added 91.21%
457 $121,000
Q2 2022

Aug 12, 2022

SELL
$301.4 - $428.42 $91,625 - $130,239
-304 Reduced 55.99%
239 $75,000
Q1 2022

May 13, 2022

SELL
$379.46 - $424.54 $80,445 - $90,002
-212 Reduced 28.08%
543 $227,000
Q4 2021

Feb 14, 2022

BUY
$373.53 - $434.12 $96,744 - $112,437
259 Added 52.22%
755 $316,000
Q2 2021

Aug 13, 2021

SELL
$372.36 - $412.07 $993,828 - $1.1 Million
-2,669 Reduced 84.33%
496 $209,000
Q1 2021

May 17, 2021

BUY
$357.26 - $392.57 $591,979 - $650,488
1,657 Added 109.88%
3,165 $1.22 Million
Q4 2020

Feb 12, 2021

BUY
$319.05 - $363.32 $481,127 - $547,886
1,508 New
1,508 $548,000
Q3 2020

Nov 12, 2020

SELL
$280.08 - $347.78 $389,591 - $483,761
-1,391 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$270.93 - $320.3 $67,732 - $80,075
250 Added 21.91%
1,391 $395,000
Q1 2020

May 14, 2020

BUY
$243.44 - $359.98 $247,335 - $365,739
1,016 Added 812.8%
1,141 $315,000
Q4 2019

Feb 14, 2020

SELL
$281.18 - $322.05 $389,996 - $446,683
-1,387 Reduced 91.73%
125 $40,000
Q3 2019

Nov 13, 2019

BUY
$294.25 - $341.49 $422,837 - $490,721
1,437 Added 1916.0%
1,512 $449,000
Q2 2019

Aug 13, 2019

BUY
$279.29 - $336.89 $20,946 - $25,266
75 New
75 $25,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Ossiam Portfolio

Follow Ossiam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.